Biomarker may predict which formerly treated cancer patients will develop highly fatal form of leukemia
from Science Daily
Patients successfully treated for breast, colon and other cancers can go on to develop an often-fatal form of leukemia, sometimes years after completion of treatment, due to a genetic mutation leading to secondary malignancies known as therapy-related myeloid neoplasms (t-MNs). A study conducted by researchers at The University of Texas MD Anderson Cancer Center revealed pre-leukemic mutations, called clonal hematopoiesis, may predict whether patients develop t-MNs.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063